RPG Life Sciences FY26 Net Profit ₹115.17 Crore, Declares ₹24 Dividend

RPG Life Sciences reported audited standalone net profit of ₹115.17 crore for FY2026 and recommended a final dividend of ₹24 per share.
The Board appointed Dr. Pratit Samdani as an Additional Non-Executive Independent Director for a five-year term effective April 29, 2026.
Auditors issued unmodified opinions on both standalone and consolidated financial results for the quarter and year ended March 31, 2026.
Exceptional items included a net insurance claim income of ₹2.475 crore and a provision of ₹1.169 crore for new Labour Codes impact.